MIR6829

Across TCGA pan-cancer cohorts, MIR6829 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR6829’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR6829 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR6829 is over-expressed in tumor, although a few such as HNSC and READ show the opposite, repressed pattern.

HNSC and READ are the cancer types where MIR6829 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6829 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	−0.358	<.001	9	view →
READ	Male	All	−1.520	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MIR6829–HNSC

Open the HNSC breakdown →